Order Article Reprints

Stepien N, Senfter D, Furtner J, Haberler C, Dorfer C, Czech T, Lötsch-Gojo D, Mayr L, Hedrich C, Baumgartner A, et al. Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 2023; 15(9):2525. https://doi.org/10.3390/cancers15092525

Stepien, Natalia, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Thomas Czech, Daniela Lötsch-Gojo, Lisa Mayr, Cora Hedrich, Alicia Baumgartner, and et al. 2023. "Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR" Cancers 15, no. 9: 2525. https://doi.org/10.3390/cancers15092525

Stepien, N., Senfter, D., Furtner, J., Haberler, C., Dorfer, C., Czech, T., Lötsch-Gojo, D., Mayr, L., Hedrich, C., Baumgartner, A., Aliotti-Lippolis, M., Schned, H., Holler, J., Bruckner, K., Slavc, I., Azizi, A. A., Peyrl, A., Müllauer, L., Madlener, S., & Gojo, J. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers, 15(9), 2525. https://doi.org/10.3390/cancers15092525